Description BioTarget is the world’s first biotech competition for emerging companies dedicated to finding new molecules for cancer treatment. Location London, England, United Kingdom Event Type Competition Regions Europe, Middle East, and Africa (EMEA) Start Date Jun 11, 2019 End Date Jun 11, 2019 Venue Name Central Working White City Event URL www.biotarget.org/ Registration URL Click here to register
Cancer is a disease that affects far too many people, with one in two being diagnosed with cancer during their lifetime.
Scientific research has already changed the lives of many suffering from this disease, but there continues to be an urgent need for new breakthroughs in cancer drug development.
BioTarget directly addresses the urgent need for
new drugs and treatments. The competition is directed at early-stage ventures aiming at developing new molecules for cancer treatment and is kindly supported by Cancer Research UK.
The competition is open to those seeking to further characterise or validate their drug target using cellular and molecular assays. We invite researchers around the world to join forces to find new drugs and bring them to market faster. Clinicians, postdoctoral researchers, established professors, virtual biotechs or even students - it is the quality of the idea that counts.
BioTarget also aims at raising awareness for entrepreneurship and innovation amongst scientists. It allows them to showcase their innovations to a greater audience and to meet leading biotech investors and industry professionals that can help them move their idea forward.
Following a first stage of the competition based on proposals submitted online, BioTarget now selects the 8 most promising projects, inviting them to a pitch event in London, UK.
During the pitch event, the finalists will present their projects, and a panel of experienced drug discovery researchers and investors will select the three winners, who will be awarded up to $100,000 in free experimentation conducted in Europe's leading cloud lab.
Agenda:
18:00 Arrival and registration
18:30 Opening
18:45 Finalists' pitches
19:30 Awards ceremony
20:00 Drinks reception
The finalists:
Macromoltek NANOGAP Therapeutics Delve Therapeutic HOX Therapeutics Synchrony Arxeon SpyCombinator - Highly combinatorial screen of multispecific ligands CDK11B: New therapies from mischaracterized drugs Generously hosted by Central Working, the UK’s premier homegrown shared workspace provider, transforming the way people work and companies grow.
__________________________ About the organisers
About Cancer Research UK
Cancer Research UK is the world's largest independent cancer research charity that conducts research into the prevention, diagnosis and treatment of the disease. Research activities are carried out in institutes, universities and hospitals across the UK, both by the charity's own employees and by its grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness of the disease and influencing public policy. Cancer Research UK's work is almost entirely funded by the public. It raises money through donations, legacies, community fundraising, events, retail and corporate partnerships. Over 40,000 people are regular volunteers.
Official Website: https://www.cancerresearchuk.org/
About Arctoris
Based in Oxford, UK, Arctoris is the world's first fully automated cloud lab for cancer research, enabling academic scientists worldwide to directly configure a wide range of cancer research experiments online, and have them completed at its robotic facility. Arctoris offers its clients and partners a wide range of techniques to cover cellular and molecular biology, providing a platform solution from experiment design via robotic experimentation to data storage and visualisation.
Arctoris is actively partnering with academic centres and drug discovery companies to move their drug candidates forward, leveraging its robotic platform to generate data of unprecedented quality and depth.
Official Website: https://arctoris.com/
About Insilico Medicine, Inc
Insilico Medicine is an artificial intelligence company headquartered in Rockville, with R&D and management resources in Belgium, Russia, UK, Taiwan, and Korea sourced through hackathons and competitions. The company and its scientists are dedicated to extending human productive longevity and transforming every step of the drug discovery and drug development process through excellence in biomarker discovery, drug development, digital medicine, and aging research.
Official Website: https://insilico.com/
